Brevan Howard Capital Management LP Travere Therapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 30,953 shares of TVTX stock, worth $635,465. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,953
Previous 61,695
49.83%
Holding current value
$635,465
Previous $863,000
37.54%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding TVTX
# of Institutions
214Shares Held
94.3MCall Options Held
1.2MPut Options Held
778K-
Black Rock Inc. New York, NY7.64MShares$157 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.36MShares$151 Million1.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.74MShares$138 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.97MShares$102 Million3.46% of portfolio
-
Macquarie Group LTD Australia, C34.26MShares$87.4 Million0.09% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.32B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...